Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Eculizumab.

Literature DB >> 19740388

Eculizumab.

Eline A Dubois, Adam F Cohen.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2009 PMID： 19740388 PMCID： PMC2766470 DOI： 10.1111/j.1365-2125.2009.03491.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

1 in total

1. Eculizumab.

Authors: Charles J Parker; Santwana Kar; Peter Kirkpatrick
Journal: Nat Rev Drug Discov Date: 2007-07 Impact factor: 84.694

1 in total

11 in total

1. Novel targets and regulatory ordeal by QT interval.

Authors: J M Ritter
Journal: Br J Clin Pharmacol Date: 2010-04 Impact factor: 4.335

Review 2. Have we overestimated the benefit of human(ized) antibodies?

Authors: Daniel R Getts; Meghann T Getts; Derrick P McCarthy; Emily M L Chastain; Stephen D Miller
Journal: MAbs Date: 2010-11-01 Impact factor: 5.857

Review 3. STEC-HUS, atypical HUS and TTP are all diseases of complement activation.

Authors: Marina Noris; Federica Mescia; Giuseppe Remuzzi
Journal: Nat Rev Nephrol Date: 2012-09-18 Impact factor: 28.314

Review 4. When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies.

Authors: Renato Mantegazza; Carlo Antozzi
Journal: Ther Adv Neurol Disord Date: 2018-01-18 Impact factor: 6.570

Review 5. Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives.

Authors: Giulia Ceglie; Laura Papetti; Massimiliano Valeriani; Pietro Merli
Journal: Int J Mol Sci Date: 2020-07-26 Impact factor: 5.923

Review 6. Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System.

Authors: Courtney M Barkoff; Shaker A Mousa
Journal: Biomedicines Date: 2020-12-24

7. Successful treatment of DEAP-HUS with eculizumab.

Authors: Damien Noone; Aoife Waters; Fred G Pluthero; Denis F Geary; Michael Kirschfink; Peter F Zipfel; Christoph Licht
Journal: Pediatr Nephrol Date: 2013-11-20 Impact factor: 3.714

8. A randomized, double-blind, single-dose, three-arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris^® ) in healthy male subjects.

Authors: Vincent Chow; Jean Pan; David Chien; Daniel T Mytych; Vladimir Hanes
Journal: Eur J Haematol Date: 2020-04-27 Impact factor: 2.997

Review 9. Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.

Authors: Jack Mellors; Tom Tipton; Stephanie Longet; Miles Carroll
Journal: Front Immunol Date: 2020-07-09 Impact factor: 7.561

Review 10. Pharmacological treatments of COVID-19.

Authors: Adeleh Sahebnasagh; Razieh Avan; Fatemeh Saghafi; Mojataba Mojtahedzadeh; Afsaneh Sadremomtaz; Omid Arasteh; Asal Tanzifi; Fatemeh Faramarzi; Reza Negarandeh; Mohammadreza Safdari; Masoud Khataminia; Hassan Rezai Ghaleno; Solomon Habtemariam; Amirhosein Khoshi
Journal: Pharmacol Rep Date: 2020-08-20 Impact factor: 3.919